DD
63
3
WBA
48
4
PBI
69
4
CRM
67
2
GIS
31
3
ILMN
42
5
MCHP
41
4
DOW
44
10
WDC
47
4
MLM
57
6
ROK
62
15
LLY
37
-3
ORLY
62
2
APD
59
2
RHI
59
2
DVN
21
3
SIG
52
3
HSIC
56
5
FDX
43
3
LB
63
22
DD
63
3
WBA
48
4
PBI
69
4
CRM
67
2
GIS
31
3
ILMN
42
5
MCHP
41
4
DOW
44
10
WDC
47
4
MLM
57
6
ROK
62
15
LLY
37
-3
ORLY
62
2
APD
59
2
RHI
59
2
DVN
21
3
SIG
52
3
HSIC
56
5
FDX
43
3
LB
63
22
Financhill
Back

LifeMD Vs. Oruka Therapeutics Industry Stock Comparison

Sell
45

LFMD
LifeMD

Last Price:
6.19
Seasonality Move:
12.53%
Sell
20

ORKA
Oruka Therapeutics

Last Price:
20.45
Seasonality Move:
--
Sell
45
LifeMD (LFMD) is a Sell

Is LifeMD a Buy, Sell or Hold?

  • The current LifeMD [LFMD] share price is $5.80. The Score for LFMD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • LFMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Oruka Therapeutics (ORKA) is a Sell

Is Oruka Therapeutics a Buy, Sell or Hold?

  • The current Oruka Therapeutics [ORKA] share price is $20.75. The Score for ORKA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LFMD Stock Price Chart

What is LifeMD's stock price today?

  • The LifeMD share price today is $5.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LFMD is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics's stock price today?

  • The Oruka Therapeutics share price today is $20.75
    The current trend is moderately bearish and ORKA is experiencing slight buying pressure.

LFMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 56.03 Buy
Chaikin Money Flow: -29692 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.2 - 6.08) Buy
Bollinger Bands (100): (4.61 - 6.29) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.7 Sell
Relative Strength Index (14 RSI): 31.86 Sell
Chaikin Money Flow: 87639 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.29 - 29.47) Sell
Bollinger Bands (100): ( - ) Buy

LFMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.77 Buy
20-day SMA: 5.33 Buy
50-day SMA: 5.04 Buy
200-day SMA: 7.15 Sell
8-day EMA: 5.69 Buy
20-day EMA: 5.46 Buy
50-day EMA: 5.29 Buy
200-day EMA: 6.14 Sell

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.54 Sell
20-day SMA: 25.55 Sell
50-day SMA: 26.16 Sell
200-day SMA: 0 Buy
8-day EMA: 22.46 Sell
20-day EMA: 24.55 Sell
50-day EMA: 11.44 Buy
200-day EMA: 3.62 Buy

LifeMD Earnings Growth & LFMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.57 per share.

Oruka Therapeutics Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.23 per share.

LifeMD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):